Ehrlichia Risticii Bacterin
DESCRIPTION: EQUINE POTOMAVAC® is a liquid suspension of inactivated Ehrlichia risticii. Safety and efficacy of this product have
been demonstrated in controlled vaccination challenge tests and in thorough
INDICATIONS: Recommended for the vaccination of
healthy horses as an aid in the prevention of Potomac Horse Fever (equine
monocytic ehrlichiosis) caused by E. risticii.
DOSAGE: For primary vaccination, aseptically
inject 1 mL (1 dose) intramuscularly into healthy horses 3 months of age or
older. Revaccinate with a second 1 mL dose 3 to 4 weeks later. Revaccinate
annually with a single 1 mL dose.
PRECAUTIONS: Store at 2-7°C (35-45°F). Do not
freeze. Use entire contents when first opened. Shake well before using. Contains
gentamicin as a preservative. Do not vaccinate within 21 days prior to
slaughter. In rare instances, administration of vaccines may cause lethargy,
fever, and inflammatory or hypersensitivity types of reactions. Treatment may
include antihistamines, anti-inflammatories, and/or epinephrine. Vaccinating
animals whose immune response is compromised by stress, disease, etc. may not
produce the desired results.
SOLD TO VETERINARIANS ONLY.
For Veterinary Use Only.
Manufactured By MERIAL INC., Athens, GA 30601 USA
U.S. Vet. Lic. No. 298
®POTOMAVAC is a registered trademark
5 x 1 Dose (1 mL)
3 x 10 Dose (10 mL)
NAC No.: 11110484